RYTM Rhythm Pharmaceuticals

Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.

$24.75  +2.14 (9.47%)
As of 09/28/2022 15:59:49 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/05/2017
Outstanding shares:  55,720,043
Average volume:  2,067,976
Market cap:   $1,148,390,086
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BF2YWG4

---

Valuation   (See tab for details)

---

PE ratio:   -8.07
PB ratio:   5.14
PS ratio:   248.73
Return on equity:   -70.46%
Net income %:   -3,598.14%